about
Performance of the digene LQ, RH and PS HPVs genotyping systems on clinical samples and comparison with HC2 and PCR-based Linear Array.Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients.Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease.The role of human papillomavirus in head and neck cancer in SenegalHuman Papillomavirus Genotype Distribution in Invasive Cervical Cancer in PakistanHPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases.Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007.Disagreement in high-grade/low-grade intraepithelial neoplasia and high-risk/low-risk HPV infection: clinical implications for anal cancer precursor lesions in HIV-positive and HIV-negative MSM.Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer.Evaluation of p16(INK4a) overexpression in a large series of cervical carcinomas: concordance with SPF10-LiPA25 PCR.Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva.Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.Type-specific human papillomavirus distribution in invasive cervical carcinomas in Paraguay. A study of 432 cases.Human papillomavirus genotype distribution in invasive cervical cancer in Bosnia and Herzegovina.Secular trends of HPV genotypes in invasive cervical cancer in Cali, Colombia 1950-1999.Potential impact of a 9-valent HPV vaccine in HPV-related cervical disease in 4 emerging countries (Brazil, Mexico, India and China).Value of p16(INK)⁴(a) in the pathology of invasive penile squamous cell carcinomas: A report of 202 cases.Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for preventionHPV types in early-onset cervical cancer – Authors' reply
P50
Q35579691-BBD6904A-7831-4CD4-9F37-9DB1154971A4Q35677549-2ABE22AA-2986-4F54-866C-79C358A9A67FQ35908027-28756EFA-6C5D-4A1F-8946-2ACCFC31D7E5Q36560944-9CA5C0B5-41ED-4F37-870A-015BCBAE8B8FQ36798192-E050DC76-9E55-43F9-8DED-322B45B987E3Q37208823-4B49C515-5A3B-4FB5-A1EC-9008B5C8C46CQ38206887-D5CD851E-ABB3-4A29-A099-C4EA4F97D2D5Q38866908-E6818598-6A1B-4532-B976-CF62168BF041Q39281387-AF0C98ED-D180-42F9-9ABB-915D9BE30285Q41472768-E3F96821-3A50-43DD-BC10-F3FCF37F594CQ42204969-6C08B1EA-E0F8-4F30-B61F-F474BA4DD17CQ42251417-1546D58E-325A-4697-86C7-2804A4C8608CQ42281397-B5DCEEC8-CAC1-4079-9418-47EEEFAE9BE2Q45206974-BA1EFB3F-16CF-48BA-8206-ED5D08174B39Q47210388-BDBB43B3-75CB-4EB1-8390-157D21A5D816Q50644081-D38DB688-8BB4-4302-8644-884924DA2BD7Q50910948-049057FA-9956-438F-A7D4-3E433F75AB2EQ51190520-163A724E-465D-43E5-9106-C59D320949A9Q54391223-BD2BF313-C423-472F-911B-0FAAD3E88ACBQ56839491-27803635-CC97-461C-8BBA-43B254D39A80Q58296152-AE0454BD-8FE9-4701-98C0-1B237CD362BB
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sara Tous
@ast
Sara Tous
@en
Sara Tous
@es
Sara Tous
@nl
Sara Tous
@sl
type
label
Sara Tous
@ast
Sara Tous
@en
Sara Tous
@es
Sara Tous
@nl
Sara Tous
@sl
prefLabel
Sara Tous
@ast
Sara Tous
@en
Sara Tous
@es
Sara Tous
@nl
Sara Tous
@sl
P106
P21
P31
P496
0000-0002-5423-7092